{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:08:14Z","timestamp":1789837694650,"version":"4.0.1"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00702-024-02865-0","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T08:11:07Z","timestamp":1732954267000},"page":"341-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cognitive impairment in Parkinson\u2019s disease and other parkinsonian syndromes"],"prefix":"10.1007","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-9979","authenticated-orcid":false,"given":"Alexandros","family":"Giannakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrissa","family":"Sioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Kloufetou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiridon","family":"Konitsiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"key":"2865_CR1","doi-asserted-by":"publisher","first-page":"45347","DOI":"10.1038\/srep45347","volume":"7","author":"A Ab\u00f3s","year":"2017","unstructured":"Ab\u00f3s A, Baggio HC, Segura B et al (2017) Discriminating cognitive status in Parkinson\u2019s disease through functional connectomics and machine learning. Sci Rep 7:45347. https:\/\/doi.org\/10.1038\/srep45347","journal-title":"Sci Rep"},{"key":"2865_CR2","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1093\/brain\/awac471","volume":"146","author":"NE Adams","year":"2023","unstructured":"Adams NE, Jafarian A, Perry A et al (2023) Neurophysiological consequences of synapse loss in progressive supranuclear palsy. Brain 146:2584\u20132594. https:\/\/doi.org\/10.1093\/brain\/awac471","journal-title":"Brain"},{"key":"2865_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 7:270\u2013279. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008","journal-title":"Alzheimer\u2019s Dement"},{"key":"2865_CR4","doi-asserted-by":"publisher","first-page":"101722","DOI":"10.1016\/j.nicl.2019.101722","volume":"22","author":"F Albrecht","year":"2019","unstructured":"Albrecht F, Bisenius S, Neumann J et al (2019) Atrophy in midbrain and cerebral\/cerebellar pedunculi is characteristic for progressive supranuclear palsy\u2014a double-validation whole-brain meta-analysis. Neuroimage Clin 22:101722. https:\/\/doi.org\/10.1016\/j.nicl.2019.101722","journal-title":"Neuroimage Clin"},{"key":"2865_CR5","doi-asserted-by":"publisher","first-page":"e0303644","DOI":"10.1371\/journal.pone.0303644","volume":"19","author":"C Altham","year":"2024","unstructured":"Altham C, Zhang H, Pereira E (2024) Machine learning for the detection and diagnosis of cognitive impairment in Parkinson\u2019s Disease: a systematic review. PLoS ONE 19:e0303644. https:\/\/doi.org\/10.1371\/journal.pone.0303644","journal-title":"PLoS ONE"},{"key":"2865_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/jnnp-2022-329342","volume":"94","author":"JN Alves","year":"2023","unstructured":"Alves JN, Westner BU, H\u00f8jlund A et al (2023) Structural and functional changes in the retina in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 94:448\u2013456. https:\/\/doi.org\/10.1136\/jnnp-2022-329342","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2865_CR7","doi-asserted-by":"publisher","unstructured":"Armstrong MJ (2019a) Lewy Body Dementias. CONTINUUM: Lifelong Learn Neurol 25:128\u2013146. https:\/\/doi.org\/10.1212\/CON.0000000000000685","DOI":"10.1212\/CON.0000000000000685"},{"key":"2865_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17562864211057666","volume":"14","author":"MJ Armstrong","year":"2021","unstructured":"Armstrong MJ (2021) Advances in dementia with Lewy bodies. Ther Adv Neurol Disord 14:1\u201314. https:\/\/doi.org\/10.1177\/17562864211057666","journal-title":"Ther Adv Neurol Disord"},{"key":"2865_CR9","doi-asserted-by":"publisher","unstructured":"Armstrong MJ (2019b) Lewy body dementias. CONTINUUM: Lifelong Learn Neurol 25:128\u2013146. https:\/\/doi.org\/10.1212\/CON.0000000000000685","DOI":"10.1212\/CON.0000000000000685"},{"key":"2865_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496\u2013503. https:\/\/doi.org\/10.1212\/WNL.0b013e31827f0fd1","journal-title":"Neurology"},{"key":"2865_CR11","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.29399\/npa.28209","volume":"59","author":"U Ay","year":"2022","unstructured":"Ay U, G\u00fcrvit \u0130H (2022) Alterations in large-scale intrinsic connectivity networks in the Parkinson\u2019s disease-associated cognitive impairment continuum: a systematic review. Arch Neuropsychiatry 59:S57\u2013S66. https:\/\/doi.org\/10.29399\/npa.28209","journal-title":"Arch Neuropsychiatry"},{"key":"2865_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41531-022-00416-6","volume":"8","author":"X Bai","year":"2022","unstructured":"Bai X, Guo T, Chen J et al (2022) Microstructural but not macrostructural cortical degeneration occurs in Parkinson\u2019s disease with mild cognitive impairment. NPJ Parkinsons Dis 8:151. https:\/\/doi.org\/10.1038\/s41531-022-00416-6","journal-title":"NPJ Parkinsons Dis"},{"key":"2865_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/13607863.2012.747083","volume":"17","author":"H B\u00e1rrios","year":"2013","unstructured":"B\u00e1rrios H, Narciso S, Guerreiro M et al (2013) Quality of life in patients with mild cognitive impairment. Aging Ment Health 17:287\u2013292. https:\/\/doi.org\/10.1080\/13607863.2012.747083","journal-title":"Aging Ment Health"},{"key":"2865_CR14","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/cells12121599","volume":"12","author":"M B\u00e9reau","year":"2023","unstructured":"B\u00e9reau M, Van Waes V, Servant M et al (2023) Apathy in Parkinson\u2019s disease: clinical patterns and neurobiological basis. Cells 12:1599. https:\/\/doi.org\/10.3390\/cells12121599","journal-title":"Cells"},{"key":"2865_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1749-6632.1996.tb34422.x","volume":"777","author":"G Binetti","year":"1996","unstructured":"Binetti G, CAPPA SF, MAGNI E, et al (1996) Disorders of visual and spatial perception in the early stage of Alzheimer\u2019s disease. Ann N Y Acad Sci 777:221\u2013225. https:\/\/doi.org\/10.1111\/j.1749-6632.1996.tb34422.x","journal-title":"Ann N Y Acad Sci"},{"key":"2865_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00702-016-1517-6","volume":"123","author":"R Biundo","year":"2016","unstructured":"Biundo R, Weis L, Bostantjopoulou S et al (2016) MMSE and MoCA in Parkinson\u2019s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. J Neural Transm 123:431\u2013438. https:\/\/doi.org\/10.1007\/s00702-016-1517-6","journal-title":"J Neural Transm"},{"key":"2865_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neurobiolaging.2014.07.009","volume":"36","author":"L Bonanni","year":"2015","unstructured":"Bonanni L, Perfetti B, Bifolchetti S et al (2015) Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies. Neurobiol Aging 36:434\u2013445. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.009","journal-title":"Neurobiol Aging"},{"key":"2865_CR18","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.3390\/ijms23126371","volume":"23","author":"O Bousiges","year":"2022","unstructured":"Bousiges O, Blanc F (2022) Biomarkers of dementia with lewy bodies: differential diagnostic with Alzheimer\u2019s disease. Int J Mol Sci 23:6371. https:\/\/doi.org\/10.3390\/ijms23126371","journal-title":"Int J Mol Sci"},{"key":"2865_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del TK, R\u00fcb U et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"2865_CR20","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/brain\/awq158","volume":"133","author":"RG Brown","year":"2010","unstructured":"Brown RG, Lacomblez L, Landwehrmeyer BG et al (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133:2382\u20132393. https:\/\/doi.org\/10.1093\/brain\/awq158","journal-title":"Brain"},{"key":"2865_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/mds.25872","volume":"29","author":"JR Burrell","year":"2014","unstructured":"Burrell JR, Hodges JR, Rowe JB (2014a) Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord 29:684\u2013693. https:\/\/doi.org\/10.1002\/mds.25872","journal-title":"Mov Disord"},{"key":"2865_CR22","doi-asserted-by":"publisher","first-page":"e92944","DOI":"10.1371\/journal.pone.0092944","volume":"9","author":"JR Burrell","year":"2014","unstructured":"Burrell JR, Hornberger M, Vucic S et al (2014b) Apraxia and motor dysfunction in corticobasal syndrome. PLoS ONE 9:e92944. https:\/\/doi.org\/10.1371\/journal.pone.0092944","journal-title":"PLoS ONE"},{"key":"2865_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1159\/000441184","volume":"5","author":"A Cagnin","year":"2015","unstructured":"Cagnin A, Buss\u00e8 C, Gardini S et al (2015) Clinical and cognitive phenotype of mild cognitive impairment evolving to dementia with Lewy bodies. Dement Geriatr Cogn Dis Extra 5:442\u2013449. https:\/\/doi.org\/10.1159\/000441184","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"2865_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00702-023-02591-z","volume":"130","author":"M Campagnolo","year":"2023","unstructured":"Campagnolo M, Weis L, Fogliano C et al (2023) Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes. J Neural Transm 130:97\u2013109. https:\/\/doi.org\/10.1007\/s00702-023-02591-z","journal-title":"J Neural Transm"},{"key":"2865_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.649051","author":"C Cao","year":"2021","unstructured":"Cao C, Wang Q, Yu H et al (2021) Morphological changes in cortical and subcortical structures in multiple system atrophy patients with mild cognitive impairment. Front Hum Neurosci. https:\/\/doi.org\/10.3389\/fnhum.2021.649051","journal-title":"Front Hum Neurosci"},{"key":"2865_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.14802\/jmd.19066","volume":"13","author":"SP Chaithra","year":"2020","unstructured":"Chaithra SP, Prasad S, Holla VV et al (2020) The non-motor symptom profile of progressive supranuclear palsy. J Mov Disord 13:118\u2013126. https:\/\/doi.org\/10.14802\/jmd.19066","journal-title":"J Mov Disord"},{"key":"2865_CR27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4103\/aian.AIAN_71_21","volume":"24","author":"K Chatterjee","year":"2021","unstructured":"Chatterjee K, Choudhury S, Siddique U et al (2021) Semantic fluency predicts gait velocity in PSP. Ann Indian Acad Neurol 24:896\u2013900. https:\/\/doi.org\/10.4103\/aian.AIAN_71_21","journal-title":"Ann Indian Acad Neurol"},{"key":"2865_CR28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/mds.25875","volume":"29","author":"BA Cholerton","year":"2014","unstructured":"Cholerton BA, Zabetian CP, Wan JY et al (2014) Evaluation of mild cognitive impairment subtypes in Parkinson\u2019s disease. Mov Disord 29:756\u2013764. https:\/\/doi.org\/10.1002\/mds.25875","journal-title":"Mov Disord"},{"key":"2865_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","volume":"93","author":"L Chouliaras","year":"2022","unstructured":"Chouliaras L, Thomas A, Malpetti M et al (2022) Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer\u2019s disease, frontotemporal dementia and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 93:651\u2013658. https:\/\/doi.org\/10.1136\/jnnp-2021-327788","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2865_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.parkreldis.2018.02.048","volume":"51","author":"SJ Chung","year":"2018","unstructured":"Chung SJ, Yoo HS, Oh JS et al (2018) Effect of striatal dopamine depletion on cognition in de novo Parkinson\u2019s disease. Parkinsonism Relat Disord 51:43\u201348. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.048","journal-title":"Parkinsonism Relat Disord"},{"key":"2865_CR31","doi-asserted-by":"publisher","first-page":"106243","DOI":"10.1016\/j.nbd.2023.106243","volume":"185","author":"RA Crockett","year":"2023","unstructured":"Crockett RA, Wilkins KB, Aditham S, Bront\u00eb-Stewart HM (2023) No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson\u2019s disease-related cognitive impairment. Neurobiol Dis 185:106243. https:\/\/doi.org\/10.1016\/j.nbd.2023.106243","journal-title":"Neurobiol Dis"},{"key":"2865_CR32","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00702-021-02372-6","volume":"128","author":"S Cuoco","year":"2021","unstructured":"Cuoco S, Picillo M, Carotenuto I et al (2021) The language profile in multiple system atrophy: an exploratory study. J Neural Transm 128:1195\u20131203. https:\/\/doi.org\/10.1007\/s00702-021-02372-6","journal-title":"J Neural Transm"},{"key":"2865_CR33","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s12311-022-01455-8","volume":"22","author":"S Cuoco","year":"2022","unstructured":"Cuoco S, Ponticorvo S, Bisogno R et al (2022) Magnetic resonance T1w\/T2w ratio in the putamen and cerebellum as a marker of cognitive impairment in MSA: a longitudinal study. The Cerebellum 22:810\u2013817. https:\/\/doi.org\/10.1007\/s12311-022-01455-8","journal-title":"The Cerebellum"},{"key":"2865_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/brain\/aww291","volume":"140","author":"SKL Darweesh","year":"2017","unstructured":"Darweesh SKL, Verlinden VJA, Stricker BH et al (2017) Trajectories of prediagnostic functioning in Parkinson\u2019s disease. Brain 140:429\u2013441. https:\/\/doi.org\/10.1093\/brain\/aww291","journal-title":"Brain"},{"key":"2865_CR35","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0000000000003770","volume":"88","author":"GS Day","year":"2017","unstructured":"Day GS, Lim TS, Hassenstab J et al (2017) Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease. Neurology 88:1273\u20131281. https:\/\/doi.org\/10.1212\/WNL.0000000000003770","journal-title":"Neurology"},{"key":"2865_CR36","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, R\u00fcb U, de Vos RAI et al (2002) Where does Parkinson disease pathology begin in the Brain? J Neuropathol Exp Neurol 61:413\u2013426. https:\/\/doi.org\/10.1093\/jnen\/61.5.413","journal-title":"J Neuropathol Exp Neurol"},{"key":"2865_CR37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","volume":"23","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Ahmed Z, Algom AA et al (2010) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394\u2013400. https:\/\/doi.org\/10.1097\/WCO.0b013e32833be924","journal-title":"Curr Opin Neurol"},{"key":"2865_CR38","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","volume":"61","author":"DW Dickson","year":"2002","unstructured":"Dickson DW, Bergeron C, Chin SS et al (2002) Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935\u2013946. https:\/\/doi.org\/10.1093\/jnen\/61.11.935","journal-title":"J Neuropathol Exp Neurol"},{"key":"2865_CR39","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE et al (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8:1150\u20131157","journal-title":"Lancet Neurol"},{"key":"2865_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","volume":"17","author":"DW Dickson","year":"2007","unstructured":"Dickson DW, Rademakers R, Hutton ML (2007) Progressive supranuclear palsy: pathology and genetics. Brain Pathol 17:74\u201382. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00054.x","journal-title":"Brain Pathol"},{"key":"2865_CR41","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB. Neurology 55:1621\u20131626. https:\/\/doi.org\/10.1212\/WNL.55.11.1621","journal-title":"Neurology"},{"key":"2865_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/13854046.2019.1670865","volume":"34","author":"K Duff","year":"2020","unstructured":"Duff K, Randolph C, Boxer AL (2020) Cognitive decline on the Repeatable Battery for the assessment of neuropsychological status in progressive supranuclear palsy. Clin Neuropsychol 34:529\u2013540. https:\/\/doi.org\/10.1080\/13854046.2019.1670865","journal-title":"Clin Neuropsychol"},{"key":"2865_CR43","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707. https:\/\/doi.org\/10.1002\/mds.21507","journal-title":"Mov Disord"},{"key":"2865_CR44","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/acn3.50987","volume":"7","author":"S Eschlb\u00f6ck","year":"2020","unstructured":"Eschlb\u00f6ck S, Delazer M, Krismer F et al (2020) Cognition in multiple system atrophy: a single-center cohort study. Ann Clin Transl Neurol 7:219\u2013228. https:\/\/doi.org\/10.1002\/acn3.50987","journal-title":"Ann Clin Transl Neurol"},{"key":"2865_CR45","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3390\/ijms24032117","volume":"24","author":"I Fatuzzo","year":"2023","unstructured":"Fatuzzo I, Niccolini GF, Zoccali F et al (2023) Neurons, nose, and neurodegenerative diseases: olfactory function and cognitive impairment. Int J Mol Sci 24:2117. https:\/\/doi.org\/10.3390\/ijms24032117","journal-title":"Int J Mol Sci"},{"key":"2865_CR46","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1212\/WNL.0b013e31822c9148","volume":"77","author":"TJ Ferman","year":"2011","unstructured":"Ferman TJ, Boeve BF, Smith GE et al (2011) Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology 77:875\u2013882. https:\/\/doi.org\/10.1212\/WNL.0b013e31822c9148","journal-title":"Neurology"},{"key":"2865_CR47","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1212\/01.wnl.0000436942.55281.47","volume":"81","author":"TJ Ferman","year":"2013","unstructured":"Ferman TJ, Smith GE, Kantarci K et al (2013) Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology 81:2032\u20132038. https:\/\/doi.org\/10.1212\/01.wnl.0000436942.55281.47","journal-title":"Neurology"},{"key":"2865_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-230026","volume":"93","author":"GG Fillenbaum","year":"2023","unstructured":"Fillenbaum GG, Mohs R (2023) CERAD (Consortium to establish a registry for Alzheimer\u2019s disease) neuropsychology assessment battery: 35 years and counting. J Alzheimer\u2019s Dis 93:1\u201327. https:\/\/doi.org\/10.3233\/JAD-230026","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2865_CR49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. J Psychiatr Res 12:189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"key":"2865_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1053\/j.semnuclmed.2020.12.003","volume":"51","author":"KA Frey","year":"2021","unstructured":"Frey KA (2021) Molecular imaging of extrapyramidal movement disorders with dementia: the 4R tauopathies. Semin Nucl Med 51:275\u2013285. https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.12.003","journal-title":"Semin Nucl Med"},{"key":"2865_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00401-008-0383-1","volume":"116","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Tsuboi Y, Lin W-L et al (2008) Co-localization of tau and \u03b1-synuclein in the olfactory bulb in Alzheimer\u2019s disease with amygdala Lewy bodies. Acta Neuropathol 116:17\u201324. https:\/\/doi.org\/10.1007\/s00401-008-0383-1","journal-title":"Acta Neuropathol"},{"key":"2865_CR52","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/13803395.2015.1087465","volume":"38","author":"I Galtier","year":"2016","unstructured":"Galtier I, Nieto A, Lorenzo JN, Barroso J (2016) Mild cognitive impairment in Parkinson\u2019s disease: diagnosis and progression to dementia. J Clin Exp Neuropsychol 38:40\u201350. https:\/\/doi.org\/10.1080\/13803395.2015.1087465","journal-title":"J Clin Exp Neuropsychol"},{"key":"2865_CR53","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jgs.15642","volume":"67","author":"M Ganguli","year":"2019","unstructured":"Ganguli M, Jia Y, Hughes TF et al (2019) Mild cognitive impairment that does not progress to dementia: a population-based study. J Am Geriatr Soc 67:232\u2013238. https:\/\/doi.org\/10.1111\/jgs.15642","journal-title":"J Am Geriatr Soc"},{"key":"2865_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8:359. https:\/\/doi.org\/10.1038\/s41392-023-01588-0","journal-title":"Signal Transduct Target Ther"},{"key":"2865_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/jnc.14719","volume":"150","author":"MS Garc\u00eda-Ayll\u00f3n","year":"2019","unstructured":"Garc\u00eda-Ayll\u00f3n MS, Monge-Argil\u00e9s JA, Monge-Garc\u00eda V et al (2019) Measurement of CSF \u03b1-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease. J Neurochem 150:218\u2013230. https:\/\/doi.org\/10.1111\/jnc.14719","journal-title":"J Neurochem"},{"key":"2865_CR56","doi-asserted-by":"publisher","first-page":"e74486","DOI":"10.1371\/journal.pone.0074486","volume":"8","author":"BCP Ghosh","year":"2013","unstructured":"Ghosh BCP, Carpenter RHS, Rowe JB (2013) A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy. PLoS ONE 8:e74486. https:\/\/doi.org\/10.1371\/journal.pone.0074486","journal-title":"PLoS ONE"},{"key":"2865_CR57","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676. https:\/\/doi.org\/10.1212\/01.wnl.0000324625.00404.15","journal-title":"Neurology"},{"key":"2865_CR58","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/brainsci13030508","volume":"13","author":"HA Gonz\u00e1lez-Usigli","year":"2023","unstructured":"Gonz\u00e1lez-Usigli HA, Ortiz GG, Charles-Ni\u00f1o C et al (2023) Neurocognitive psychiatric and neuropsychological alterations in Parkinson\u2019s disease: a basic and clinical approach. Brain Sci 13:508. https:\/\/doi.org\/10.3390\/brainsci13030508","journal-title":"Brain Sci"},{"key":"2865_CR59","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00415-017-8579-8","volume":"264","author":"M Gorges","year":"2017","unstructured":"Gorges M, Maier MN, Rosskopf J et al (2017) Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes. J Neurol 264:1919\u20131928. https:\/\/doi.org\/10.1007\/s00415-017-8579-8","journal-title":"J Neurol"},{"key":"2865_CR60","doi-asserted-by":"publisher","first-page":"e0304355","DOI":"10.1371\/journal.pone.0304355","volume":"19","author":"A Gorji","year":"2024","unstructured":"Gorji A, Fathi Jouzdani A (2024) Machine learning for predicting cognitive decline within five years in Parkinson\u2019s disease: comparing cognitive assessment scales with DAT SPECT and clinical biomarkers. PLoS ONE 19:e0304355. https:\/\/doi.org\/10.1371\/journal.pone.0304355","journal-title":"PLoS ONE"},{"key":"2865_CR61","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006\u20131014. https:\/\/doi.org\/10.1212\/WNL.0b013e31821103e6","journal-title":"Neurology"},{"key":"2865_CR62","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/mds.23669","volume":"26","author":"G Halliday","year":"2011","unstructured":"Halliday G, Lees A, Stern M (2011) Milestones in Parkinson\u2019s disease\u2014clinical and pathologic features. Mov Disord 26:1015\u20131021. https:\/\/doi.org\/10.1002\/mds.23669","journal-title":"Mov Disord"},{"key":"2865_CR63","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/brainsci13020242","volume":"13","author":"N Hansen","year":"2023","unstructured":"Hansen N, Bouter C, M\u00fcller SJ et al (2023) New insights into potential biomarkers in patients with mild cognitive impairment occurring in the prodromal stage of dementia with lewy bodies. Brain Sci 13:242. https:\/\/doi.org\/10.3390\/brainsci13020242","journal-title":"Brain Sci"},{"key":"2865_CR64","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/brain\/awf251","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease. Brain 125:2431\u20132445. https:\/\/doi.org\/10.1093\/brain\/awf251","journal-title":"Brain"},{"key":"2865_CR65","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/13854046.2014.892155","volume":"28","author":"A Harry","year":"2014","unstructured":"Harry A, Crowe SF (2014) Is the Boston naming test still fit for purpose? Clin Neuropsychol 28:486\u2013504. https:\/\/doi.org\/10.1080\/13854046.2014.892155","journal-title":"Clin Neuropsychol"},{"key":"2865_CR66","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"key":"2865_CR67","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1007\/s00415-011-6404-3","volume":"259","author":"JY Hong","year":"2012","unstructured":"Hong JY, Lee JE, Sohn YH, Lee PH (2012) Neurocognitive and atrophic patterns in Parkinson\u2019s disease based on subjective memory complaints. J Neurol 259:1706\u20131712. https:\/\/doi.org\/10.1007\/s00415-011-6404-3","journal-title":"J Neurol"},{"key":"2865_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.22059","volume":"16","author":"JY Hong","year":"2023","unstructured":"Hong JY, Lee PH (2023) Subjective cognitive complaints in cognitively normal patients with Parkinson\u2019s disease: a systematic review. J Mov Disord 16:1\u201312. https:\/\/doi.org\/10.14802\/jmd.22059","journal-title":"J Mov Disord"},{"key":"2865_CR69","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3233\/JAD-215327","volume":"88","author":"E Howard","year":"2022","unstructured":"Howard E, Ballinger S, Kinney NG et al (2022) Frontal atrophy and executive dysfunction relate to complex numbers impairment in progressive supranuclear palsy. J Alzheimer\u2019s Dis 88:1553\u20131566. https:\/\/doi.org\/10.3233\/JAD-215327","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2865_CR70","doi-asserted-by":"publisher","first-page":"14241","DOI":"10.1038\/s41598-023-41569-5","volume":"13","author":"M Huang","year":"2023","unstructured":"Huang M, Yu H, Cai X et al (2023) A comparative study of posterior cingulate metabolism in patients with mild cognitive impairment due to Parkinson\u2019s disease or Alzheimer\u2019s disease. Sci Rep 13:14241. https:\/\/doi.org\/10.1038\/s41598-023-41569-5","journal-title":"Sci Rep"},{"key":"2865_CR71","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/10738584211011979","volume":"29","author":"A Hussein","year":"2023","unstructured":"Hussein A, Guevara CA, Del Valle P et al (2023) Non-motor symptoms of Parkinson\u2019s disease: the neurobiology of early psychiatric and cognitive dysfunction. Neuroscientist 29:97\u2013116. https:\/\/doi.org\/10.1177\/10738584211011979","journal-title":"Neuroscientist"},{"key":"2865_CR72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","volume":"77","author":"E Jabbari","year":"2020","unstructured":"Jabbari E, Holland N, Chelban V et al (2020) Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome. JAMA Neurol 77:377\u2013387. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4347","journal-title":"JAMA Neurol"},{"key":"2865_CR73","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00702-022-02559-5","volume":"129","author":"KA Jellinger","year":"2022","unstructured":"Jellinger KA (2022) The pathobiological basis of depression in Parkinson disease: challenges and outlooks. J Neural Transm 129:1397\u20131418. https:\/\/doi.org\/10.1007\/s00702-022-02559-5","journal-title":"J Neural Transm"},{"key":"2865_CR74","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3233\/JAD-170397","volume":"62","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018) Multiple system atrophy: an oligodendroglioneural synucleinopathy1. J Alzheimer\u2019s Dis 62:1141\u20131179. https:\/\/doi.org\/10.3233\/JAD-170397","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2865_CR75","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.neurobiolaging.2008.09.017","volume":"31","author":"GA Jicha","year":"2010","unstructured":"Jicha GA, Schmitt FA, Abner E et al (2010) Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging 31:1805\u20131813. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.09.017","journal-title":"Neurobiol Aging"},{"key":"2865_CR76","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1007\/s00259-023-06154-y","volume":"50","author":"M Jreige","year":"2023","unstructured":"Jreige M, Kurian GK, Perriraz J et al (2023) The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review. Eur J Nucl Med Mol Imaging 50:1988\u20132035. https:\/\/doi.org\/10.1007\/s00259-023-06154-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2865_CR77","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3390\/life11121411","volume":"11","author":"K Kadota","year":"2021","unstructured":"Kadota K, Onoda K, Abe S et al (2021) Multiscale entropy of resting-state functional magnetic resonance imaging differentiates progressive supranuclear palsy and multiple system atrophy. Life 11:1411. https:\/\/doi.org\/10.3390\/life11121411","journal-title":"Life"},{"key":"2865_CR78","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.3233\/JPD-181473","volume":"8","author":"E Kalbe","year":"2018","unstructured":"Kalbe E, Aarsland D, Folkerts A-K (2018) Cognitive interventions in Parkinson\u2019s disease: where we want to go within 20 years. J Parkinsons Dis 8:S107\u2013S113. https:\/\/doi.org\/10.3233\/JPD-181473","journal-title":"J Parkinsons Dis"},{"key":"2865_CR79","doi-asserted-by":"publisher","DOI":"10.3233\/jpd-230050","author":"AV Karacan","year":"2023","unstructured":"Karacan AV, Kibrit SN, Yeked\u00fcz MK et al (2023) Cross-cultural differences in stigma associated with Parkinson\u2019s disease: a systematic review. J Parkinsons Dis. https:\/\/doi.org\/10.3233\/jpd-230050","journal-title":"J Parkinsons Dis"},{"key":"2865_CR80","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/jnnp-2017-315813","volume":"89","author":"S Koga","year":"2018","unstructured":"Koga S, Dickson DW (2018) Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. J Neurol Neurosurg Psychiatry 89:175\u2013184. https:\/\/doi.org\/10.1136\/jnnp-2017-315813","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2865_CR81","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1136\/jnnp-2017-317398","volume":"89","author":"J Komatsu","year":"2018","unstructured":"Komatsu J, Samuraki M, Nakajima K et al (2018) 123I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study. J Neurol Neurosurg Psychiatry 89:1167\u20131173. https:\/\/doi.org\/10.1136\/jnnp-2017-317398","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2865_CR82","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jns.2016.08.011","volume":"369","author":"D Kondo","year":"2016","unstructured":"Kondo D, Ota K, Kasanuki K et al (2016) Characteristics of mild cognitive impairment tending to convert into Alzheimer\u2019s disease or dementia with Lewy bodies: a follow-up study in a memory clinic. J Neurol Sci 369:102\u2013108. https:\/\/doi.org\/10.1016\/j.jns.2016.08.011","journal-title":"J Neurol Sci"},{"key":"2865_CR83","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1093\/brain\/awr234","volume":"134","author":"N Kouri","year":"2011","unstructured":"Kouri N, Murray ME, Hassan A et al (2011a) Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain 134:3264\u20133275. https:\/\/doi.org\/10.1093\/brain\/awr234","journal-title":"Brain"},{"key":"2865_CR84","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrneurol.2011.43","volume":"7","author":"N Kouri","year":"2011","unstructured":"Kouri N, Whitwell JL, Josephs KA et al (2011b) Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol 7:263\u2013272. https:\/\/doi.org\/10.1038\/nrneurol.2011.43","journal-title":"Nat Rev Neurol"},{"key":"2865_CR85","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3238\/arztebl.2016.0061","volume":"113","author":"J Levin","year":"2016","unstructured":"Levin J, Kurz A, Arzberger T et al (2016) The differential diagnosis and treatment of atypical parkinsonism. Dtsch Arztebl Int 113:61\u201369. https:\/\/doi.org\/10.3238\/arztebl.2016.0061","journal-title":"Dtsch Arztebl Int"},{"key":"2865_CR86","doi-asserted-by":"publisher","first-page":"e0269787","DOI":"10.1371\/journal.pone.0269787","volume":"17","author":"L Li","year":"2022","unstructured":"Li L, Ji B, Zhao T et al (2022) The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments. PLoS ONE 17:e0269787. https:\/\/doi.org\/10.1371\/journal.pone.0269787","journal-title":"PLoS ONE"},{"key":"2865_CR87","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1038\/s41598-021-84393-5","volume":"11","author":"N Li","year":"2021","unstructured":"Li N, Yang T, Ran W et al (2021) A study on the characteristics of cognitive function in patients with multiple system atrophy in China. Sci Rep 11:4995. https:\/\/doi.org\/10.1038\/s41598-021-84393-5","journal-title":"Sci Rep"},{"key":"2865_CR88","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/hbm.26058","volume":"44","author":"Y Li","year":"2023","unstructured":"Li Y, Liu H, Yu H et al (2023) Alterations of voxel-wise spontaneous activity and corresponding brain functional networks in multiple system atrophy patients with mild cognitive impairment. Hum Brain Mapp 44:403\u2013417. https:\/\/doi.org\/10.1002\/hbm.26058","journal-title":"Hum Brain Mapp"},{"key":"2865_CR89","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.3390\/ijms21186914","volume":"21","author":"C-H Lin","year":"2020","unstructured":"Lin C-H, Chiu S-I, Chen T-F et al (2020) Classifications of neurodegenerative disorders using a multiplex blood biomarkers-based machine learning model. Int J Mol Sci 21:6914. https:\/\/doi.org\/10.3390\/ijms21186914","journal-title":"Int J Mol Sci"},{"key":"2865_CR90","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/mds.23823","volume":"26","author":"I Litvan","year":"2011","unstructured":"Litvan I, Aarsland D, Adler CH et al (2011) MDS task force on mild cognitive impairment in Parkinson\u2019s disease: critical review of PD-MCI. Mov Disord 26:1814\u20131824. https:\/\/doi.org\/10.1002\/mds.23823","journal-title":"Mov Disord"},{"key":"2865_CR91","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349\u2013356. https:\/\/doi.org\/10.1002\/mds.24893","journal-title":"Mov Disord"},{"key":"2865_CR92","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/mds.25843","volume":"29","author":"I Litvan","year":"2014","unstructured":"Litvan I, Kong M (2014) Rate of decline in progressive supranuclear palsy. Mov Disord 29:463\u2013468. https:\/\/doi.org\/10.1002\/mds.25843","journal-title":"Mov Disord"},{"key":"2865_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.881369","author":"F Maass","year":"2022","unstructured":"Maass F, Hermann P, Varges D et al (2022) Prospective CERAD neuropsychological assessment in patients with multiple system atrophy. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2022.881369","journal-title":"Front Neurol"},{"key":"2865_CR94","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/13554794.2018.1527368","volume":"24","author":"NK Magdalinou","year":"2018","unstructured":"Magdalinou NK, Golden HL, Nicholas JM et al (2018) Verbal adynamia in parkinsonian syndromes: behavioral correlates and neuroanatomical substrate. Neurocase 24:204\u2013212. https:\/\/doi.org\/10.1080\/13554794.2018.1527368","journal-title":"Neurocase"},{"key":"2865_CR95","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/aian.AIAN_611_20","volume":"24","author":"RR Mahale","year":"2021","unstructured":"Mahale RR, Krishnan S, Divya KP et al (2021) Subtypes of PSP and prognosis: a retrospective analysis. Ann Indian Acad Neurol 24:56\u201362. https:\/\/doi.org\/10.4103\/aian.AIAN_611_20","journal-title":"Ann Indian Acad Neurol"},{"key":"2865_CR96","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41586-019-1858-z","volume":"577","author":"JC Marques","year":"2020","unstructured":"Marques JC, Li M, Schaak D et al (2020) Internal state dynamics shape brainwide activity and foraging behaviour. Nature 577:239\u2013243. https:\/\/doi.org\/10.1038\/s41586-019-1858-z","journal-title":"Nature"},{"key":"2865_CR97","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1212\/01.wnl.0000434309.85312.19","volume":"55","author":"PS Mathuranath","year":"2000","unstructured":"Mathuranath PS, Nestor PJ, Berrios GE et al (2000) A brief cognitive test battery to differentiate Alzheimer\u2019s disease and frontotemporal dementia. Neurology 55:1613\u20131620. https:\/\/doi.org\/10.1212\/01.wnl.0000434309.85312.19","journal-title":"Neurology"},{"key":"2865_CR98","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies. Neurology 89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"2865_CR99","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ et al (2020) Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94:743\u2013755. https:\/\/doi.org\/10.1212\/WNL.0000000000009323","journal-title":"Neurology"},{"key":"2865_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00146","author":"M Medina","year":"2020","unstructured":"Medina M, Avila J (2020) Editorial: untangling the role of tau in physiology and pathology. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2020.00146","journal-title":"Front Aging Neurosci"},{"key":"2865_CR101","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","volume":"58","author":"PT Meyer","year":"2017","unstructured":"Meyer PT, Frings L, R\u00fccker G, Hellwig S (2017) 18F-FDG PET in Parkinsonism: differential diagnosis and evaluation of cognitive impairment. J Nucl Med 58:1888\u20131898. https:\/\/doi.org\/10.2967\/jnumed.116.186403","journal-title":"J Nucl Med"},{"key":"2865_CR102","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/biomedicines11020541","volume":"11","author":"L Miquel-Rio","year":"2023","unstructured":"Miquel-Rio L, Sarri\u00e9s-Serrano U, Pavia-Collado R et al (2023) The role of \u03b1-synuclein in the regulation of serotonin system: physiological and pathological features. Biomedicines 11:541. https:\/\/doi.org\/10.3390\/biomedicines11020541","journal-title":"Biomedicines"},{"key":"2865_CR103","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47004","author":"AA Mohamed","year":"2023","unstructured":"Mohamed AA, Marques O (2023) Diagnostic efficacy and clinical relevance of artificial intelligence in detecting cognitive decline. Cureus. https:\/\/doi.org\/10.7759\/cureus.47004","journal-title":"Cureus"},{"key":"2865_CR104","doi-asserted-by":"publisher","first-page":"101470","DOI":"10.1016\/j.diabet.2023.101470","volume":"49","author":"M Monney","year":"2023","unstructured":"Monney M, Jornayvaz FR, Gariani K (2023) GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes. Diabetes Metab 49:101470. https:\/\/doi.org\/10.1016\/j.diabet.2023.101470","journal-title":"Diabetes Metab"},{"key":"2865_CR105","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.parkreldis.2017.11.343","volume":"47","author":"R Morisi","year":"2018","unstructured":"Morisi R, Manners DN, Gnecco G et al (2018) Multi-class parkinsonian disorders classification with quantitative MR markers and graph-based features using support vector machines. Parkinsonism Relat Disord 47:64\u201370. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.11.343","journal-title":"Parkinsonism Relat Disord"},{"key":"2865_CR106","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC (1993) The clinical dementia rating (CDR). Neurology 43:2412. https:\/\/doi.org\/10.1212\/WNL.43.11.2412-a","journal-title":"Neurology"},{"key":"2865_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.616357","author":"H Murakami","year":"2021","unstructured":"Murakami H, Ono K, Shiraishi T et al (2021) Mini review: correlations of cognitive domains with cerebrospinal fluid \u03b1-synuclein levels in patients with Parkinson\u2019s disease. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2020.616357","journal-title":"Front Aging Neurosci"},{"key":"2865_CR108","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00429-014-0924-4","volume":"221","author":"A Muzerelle","year":"2016","unstructured":"Muzerelle A, Scotto-Lomassese S, Bernard JF et al (2016) Conditional anterograde tracing reveals distinct targeting of individual serotonin cell groups (B5\u2013B9) to the forebrain and brainstem. Brain Struct Funct 221:535\u2013561. https:\/\/doi.org\/10.1007\/s00429-014-0924-4","journal-title":"Brain Struct Funct"},{"key":"2865_CR109","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"2865_CR110","doi-asserted-by":"publisher","first-page":"e0277798","DOI":"10.1371\/journal.pone.0277798","volume":"17","author":"A Nasri","year":"2022","unstructured":"Nasri A, Gharbi A, Sghaier I et al (2022) Determinants of cognitive impairment in multiple system atrophy: clinical and genetic study. PLoS ONE 17:e0277798. https:\/\/doi.org\/10.1371\/journal.pone.0277798","journal-title":"PLoS ONE"},{"key":"2865_CR111","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1007\/s00259-018-4104-2","volume":"45","author":"F Niccolini","year":"2018","unstructured":"Niccolini F, Wilson H, Hirschbichler S et al (2018) Disease-related patterns of in vivo pathology in corticobasal syndrome. Eur J Nucl Med Mol Imaging 45:2413\u20132425. https:\/\/doi.org\/10.1007\/s00259-018-4104-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2865_CR112","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/ene.13728","volume":"25","author":"F Nobili","year":"2018","unstructured":"Nobili F, Arbizu J, Bouwman F et al (2018) European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol 25:1201\u20131217. https:\/\/doi.org\/10.1111\/ene.13728","journal-title":"Eur J Neurol"},{"key":"2865_CR113","doi-asserted-by":"publisher","first-page":"101979","DOI":"10.1016\/j.arr.2023.101979","volume":"89","author":"J Nowell","year":"2023","unstructured":"Nowell J, Blunt E, Gupta D, Edison P (2023) Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease. Ageing Res Rev 89:101979. https:\/\/doi.org\/10.1016\/j.arr.2023.101979","journal-title":"Ageing Res Rev"},{"key":"2865_CR114","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1590\/0004-282x20170077","volume":"75","author":"LM de Oliveira","year":"2017","unstructured":"de Oliveira LM, Barcellos I, Teive HAG, Munhoz RP (2017) Cognitive dysfunction in corticobasal degeneration. Arq Neuropsiquiatr 75:570\u2013579. https:\/\/doi.org\/10.1590\/0004-282x20170077","journal-title":"Arq Neuropsiquiatr"},{"key":"2865_CR115","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","volume":"76","author":"B Olsson","year":"2019","unstructured":"Olsson B, Portelius E, Cullen NC et al (2019) Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders. JAMA Neurol 76:318\u2013325. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3746","journal-title":"JAMA Neurol"},{"key":"2865_CR116","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41531-022-00304-z","volume":"8","author":"P Ortelli","year":"2022","unstructured":"Ortelli P, Ferrazzoli D, Versace V et al (2022) Optimization of cognitive assessment in Parkinsonisms by applying artificial intelligence to a comprehensive screening test. NPJ Parkinsons Dis 8:42. https:\/\/doi.org\/10.1038\/s41531-022-00304-z","journal-title":"NPJ Parkinsons Dis"},{"key":"2865_CR117","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(48)90691-6","volume":"252","author":"R Orton","year":"1948","unstructured":"Orton R (1948) Psychiatric screening of medical students. The Lancet 252:321\u2013323. https:\/\/doi.org\/10.1016\/S0140-6736(48)90691-6","journal-title":"The Lancet"},{"key":"2865_CR118","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s11548-023-02866-6","volume":"18","author":"C Ostertag","year":"2023","unstructured":"Ostertag C, Visani M, Urruty T, Beurton-Aimar M (2023) Long-term cognitive decline prediction based on multi-modal data using Multimodal3DSiameseNet: transfer learning from Alzheimer\u2019s disease to Parkinson\u2019s disease. Int J Comput Assist Radiol Surg 18:809\u2013818. https:\/\/doi.org\/10.1007\/s11548-023-02866-6","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"2865_CR119","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/brain\/awn065","volume":"131","author":"SS O\u2019Sullivan","year":"2008","unstructured":"O\u2019Sullivan SS, Massey LA, Williams DR et al (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131:1362\u20131372. https:\/\/doi.org\/10.1093\/brain\/awn065","journal-title":"Brain"},{"key":"2865_CR120","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1007\/s00415-020-09985-z","volume":"267","author":"G Palermo","year":"2020","unstructured":"Palermo G, Del Prete E, Bonuccelli U, Ceravolo R (2020) Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between \u03b1-synucleinopathies. J Neurol 267:3444\u20133456. https:\/\/doi.org\/10.1007\/s00415-020-09985-z","journal-title":"J Neurol"},{"key":"2865_CR121","doi-asserted-by":"publisher","unstructured":"Pantelyat A (2022) Progressive supranuclear palsy and corticobasal syndrome. CONTINUUM: Lifelong Learn Neurol 28:1364\u20131378. https:\/\/doi.org\/10.1212\/CON.0000000000001158","DOI":"10.1212\/CON.0000000000001158"},{"key":"2865_CR122","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41531-023-00509-w","volume":"9","author":"F Paolini Paoletti","year":"2023","unstructured":"Paolini Paoletti F, Gaetani L, Bellomo G et al (2023) CSF neurochemical profile and cognitive changes in Parkinson\u2019s disease with mild cognitive impairment. NPJ Parkinsons Dis 9:68. https:\/\/doi.org\/10.1038\/s41531-023-00509-w","journal-title":"NPJ Parkinsons Dis"},{"key":"2865_CR123","doi-asserted-by":"publisher","first-page":"e0286506","DOI":"10.1371\/journal.pone.0286506","volume":"18","author":"M Parajuli","year":"2023","unstructured":"Parajuli M, Amara AW, Shaban M (2023) Deep-learning detection of mild cognitive impairment from sleep electroencephalography for patients with Parkinson\u2019s disease. PLoS ONE 18:e0286506. https:\/\/doi.org\/10.1371\/journal.pone.0286506","journal-title":"PLoS ONE"},{"key":"2865_CR124","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/mds.28373","volume":"36","author":"JB Parmera","year":"2021","unstructured":"Parmera JB, Coutinho AM, Aranha MR et al (2021) FDG-PET patterns predict amyloid deposition and clinical profile in corticobasal syndrome. Mov Disord 36:651\u2013661. https:\/\/doi.org\/10.1002\/mds.28373","journal-title":"Mov Disord"},{"key":"2865_CR125","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejphar.2014.05.064","volume":"753","author":"T Pattij","year":"2015","unstructured":"Pattij T, Schoffelmeer ANM (2015) Serotonin and inhibitory response control: focusing on the role of 5-HT1A receptors. Eur J Pharmacol 753:140\u2013145. https:\/\/doi.org\/10.1016\/j.ejphar.2014.05.064","journal-title":"Eur J Pharmacol"},{"key":"2865_CR126","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/ane.12365","volume":"131","author":"MT Pellecchia","year":"2015","unstructured":"Pellecchia MT, Picillo M, Santangelo G et al (2015) Cognitive performances and DAT imaging in early Parkinson\u2019s disease with mild cognitive impairment: a preliminary study. Acta Neurol Scand 131:275\u2013281. https:\/\/doi.org\/10.1111\/ane.12365","journal-title":"Acta Neurol Scand"},{"key":"2865_CR127","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000479110","volume":"17","author":"A Pilotto","year":"2017","unstructured":"Pilotto A, Gazzina S, Benussi A et al (2017) Mild cognitive impairment and progression to dementia in progressive supranuclear palsy. Neurodegener Dis 17:286\u2013291. https:\/\/doi.org\/10.1159\/000479110","journal-title":"Neurodegener Dis"},{"key":"2865_CR128","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/ene.14115","volume":"27","author":"R Piredda","year":"2020","unstructured":"Piredda R, Desmarais P, Masellis M, Gasca-Salas C (2020) Cognitive and psychiatric symptoms in genetically determined Parkinson\u2019s disease: a systematic review. Eur J Neurol 27:229\u2013234. https:\/\/doi.org\/10.1111\/ene.14115","journal-title":"Eur J Neurol"},{"key":"2865_CR129","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"2865_CR130","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1111\/ene.15481","volume":"29","author":"D Pourzinal","year":"2022","unstructured":"Pourzinal D, Yang J, Lawson RA et al (2022) Systematic review of data-driven cognitive subtypes in Parkinson disease. Eur J Neurol 29:3395\u20133417. https:\/\/doi.org\/10.1111\/ene.15481","journal-title":"Eur J Neurol"},{"key":"2865_CR131","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10916-022-01836-w","volume":"46","author":"J Prats-Climent","year":"2022","unstructured":"Prats-Climent J, Gandia-Ferrero MT, Torres-Espallardo I et al (2022) Artificial intelligence on FDG PET images identifies mild cognitive impairment patients with neurodegenerative disease. J Med Syst 46:52. https:\/\/doi.org\/10.1007\/s10916-022-01836-w","journal-title":"J Med Syst"},{"key":"2865_CR132","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12035-011-8214-0","volume":"44","author":"MV Puig","year":"2011","unstructured":"Puig MV, Gulledge AT (2011) Serotonin and prefrontal cortex function: neurons, networks, and circuits. Mol Neurobiol 44:449\u2013464. https:\/\/doi.org\/10.1007\/s12035-011-8214-0","journal-title":"Mol Neurobiol"},{"key":"2865_CR133","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","volume":"20","author":"C Randolph","year":"1998","unstructured":"Randolph C, Tierney MC, Mohr E, Chase TN (1998) The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20:310\u2013319. https:\/\/doi.org\/10.1076\/jcen.20.3.310.823","journal-title":"J Clin Exp Neuropsychol"},{"key":"2865_CR134","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456\u20132477. https:\/\/doi.org\/10.1093\/brain\/awr179","journal-title":"Brain"},{"key":"2865_CR135","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/antiox12051117","volume":"12","author":"SM Ravenhill","year":"2023","unstructured":"Ravenhill SM, Evans AH, Crewther SG (2023) Escalating bi-directional feedback loops between proinflammatory microglia and mitochondria in ageing and post-diagnosis of Parkinson\u2019s disease. Antioxidants 12:1117. https:\/\/doi.org\/10.3390\/antiox12051117","journal-title":"Antioxidants"},{"key":"2865_CR136","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J et al (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23:12841. https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"key":"2865_CR137","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12888-016-1132-y","volume":"16","author":"O Realdon","year":"2016","unstructured":"Realdon O, Rossetto F, Nalin M et al (2016) Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial. BMC Psychiatry 16:425. https:\/\/doi.org\/10.1186\/s12888-016-1132-y","journal-title":"BMC Psychiatry"},{"key":"2865_CR138","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"RM Reitan","year":"1958","unstructured":"Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271\u2013276. https:\/\/doi.org\/10.2466\/pms.1958.8.3.271","journal-title":"Percept Mot Skills"},{"key":"2865_CR139","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.27034","volume":"32","author":"G Respondek","year":"2017","unstructured":"Respondek G, Kurz C, Arzberger T et al (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 32:995\u20131005. https:\/\/doi.org\/10.1002\/mds.27034","journal-title":"Mov Disord"},{"key":"2865_CR140","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/jnnp-2012-303618","volume":"84","author":"T Rittman","year":"2013","unstructured":"Rittman T, Ghosh BC, McColgan P et al (2013) The Addenbrooke\u2019s cognitive examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders. J Neurol Neurosurg Psychiatry 84:544\u2013551. https:\/\/doi.org\/10.1136\/jnnp-2012-303618","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2865_CR141","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.002","volume":"73","author":"SG Ryman","year":"2020","unstructured":"Ryman SG, Poston KL (2020) MRI biomarkers of motor and non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 73:85\u201393. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.10.002","journal-title":"Parkinsonism Relat Disord"},{"key":"2865_CR142","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1007\/s12035-023-03359-y","volume":"60","author":"SS Sabari","year":"2023","unstructured":"Sabari SS, Balasubramani K, Iyer M et al (2023) Type 2 diabetes (T2DM) and Parkinson\u2019s disease (PD): a mechanistic approach. Mol Neurobiol 60:4547\u20134573. https:\/\/doi.org\/10.1007\/s12035-023-03359-y","journal-title":"Mol Neurobiol"},{"key":"2865_CR143","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3233\/JAD-161089","volume":"58","author":"D Sadiq","year":"2017","unstructured":"Sadiq D, Whitfield T, Lee L et al (2017) Prodromal dementia with lewy bodies and prodromal Alzheimer\u2019s disease: a comparison of the cognitive and clinical profiles. J Alzheimer\u2019s Dis 58:463\u2013470. https:\/\/doi.org\/10.3233\/JAD-161089","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2865_CR144","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1212\/WNL.0000000000009734","volume":"95","author":"N Sakae","year":"2020","unstructured":"Sakae N, Santos OA, Pedraza O et al (2020) Clinical and pathologic features of cognitive-predominant corticobasal degeneration. Neurology 95:35\u201345. https:\/\/doi.org\/10.1212\/WNL.0000000000009734","journal-title":"Neurology"},{"key":"2865_CR145","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrn.2017.91","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Erratum: non-motor features of Parkinson disease. Nat Rev Neurosci 18:509\u2013509. https:\/\/doi.org\/10.1038\/nrn.2017.91","journal-title":"Nat Rev Neurosci"},{"key":"2865_CR146","doi-asserted-by":"publisher","unstructured":"Schneider JA (2022) Neuropathology of dementia disorders. CONTINUUM: Lifelong Learn Neurol 28:834\u2013851. https:\/\/doi.org\/10.1212\/CON.0000000000001137","DOI":"10.1212\/CON.0000000000001137"},{"key":"2865_CR147","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3233\/JPD-181568","volume":"9","author":"M Seki","year":"2019","unstructured":"Seki M, Seppi K, Mueller C et al (2019) Diagnostic potential of multimodal MRI markers in atypical Parkinsonian disorders. J Parkinsons Dis 9:681\u2013691. https:\/\/doi.org\/10.3233\/JPD-181568","journal-title":"J Parkinsons Dis"},{"key":"2865_CR148","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.21037\/qims-20-1259","volume":"11","author":"S Shang","year":"2021","unstructured":"Shang S, Wu J, Chen Y-C et al (2021) Aberrant cerebral perfusion pattern in amnestic mild cognitive impairment and Parkinson\u2019s disease with mild cognitive impairment: a comparative arterial spin labeling study. Quant Imaging Med Surg 11:3082\u20133097. https:\/\/doi.org\/10.21037\/qims-20-1259","journal-title":"Quant Imaging Med Surg"},{"key":"2865_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.652059","author":"C Shen","year":"2021","unstructured":"Shen C, Chen L, Ge JJ et al (2021) Cerebral metabolism related to cognitive impairments in multiple system atrophy. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.652059","journal-title":"Front Neurol"},{"key":"2865_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.788166","author":"C Shen","year":"2022","unstructured":"Shen C, Chen QS, Zuo CT et al (2022) The frontal and cerebellar metabolism related to cognitive dysfunction in multiple system atrophy. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2022.788166","journal-title":"Front Aging Neurosci"},{"key":"2865_CR151","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/nprot.2006.115","volume":"1","author":"M-S Shin","year":"2006","unstructured":"Shin M-S, Park S-Y, Park S-R et al (2006) Clinical and empirical applications of the Rey-Osterrieth complex figure test. Nat Protoc 1:892\u2013899. https:\/\/doi.org\/10.1038\/nprot.2006.115","journal-title":"Nat Protoc"},{"key":"2865_CR152","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/pharmaceutics15082051","volume":"15","author":"N Siwecka","year":"2023","unstructured":"Siwecka N, Saramowicz K, Galita G et al (2023) Inhibition of protein aggregation and endoplasmic reticulum stress as a targeted therapy for \u03b1-synucleinopathy. Pharmaceutics 15:2051. https:\/\/doi.org\/10.3390\/pharmaceutics15082051","journal-title":"Pharmaceutics"},{"key":"2865_CR153","doi-asserted-by":"publisher","first-page":"105309","DOI":"10.1016\/j.parkreldis.2023.105309","volume":"110","author":"K Smilowska","year":"2023","unstructured":"Smilowska K, van Wamelen DJ, Bloem BR (2023) The multimodal effect of circadian interventions in Parkinson\u2019s disease: a narrative review. Parkinsonism Relat Disord 110:105309. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105309","journal-title":"Parkinsonism Relat Disord"},{"key":"2865_CR154","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-321111","author":"C Smith","year":"2019","unstructured":"Smith C, Malek N, Grosset K et al (2019) Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2019-321111","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2865_CR155","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3233\/JPD-212705","volume":"11","author":"A Snyder","year":"2021","unstructured":"Snyder A, Gruber-Baldini AL, Rainer von Coelln F et al (2021) Comparison of mini-mental state examination and montreal cognitive assessment ratings across levels of Parkinson\u2019s disease severity. J Parkinsons Dis 11:1995\u20132003. https:\/\/doi.org\/10.3233\/JPD-212705","journal-title":"J Parkinsons Dis"},{"key":"2865_CR156","doi-asserted-by":"publisher","first-page":"e0280609","DOI":"10.1371\/journal.pone.0280609","volume":"18","author":"M Sood","year":"2023","unstructured":"Sood M, Suenkel U, von Thaler A-K et al (2023) Bayesian network modeling of risk and prodromal markers of Parkinson\u2019s disease. PLoS ONE 18:e0280609. https:\/\/doi.org\/10.1371\/journal.pone.0280609","journal-title":"PLoS ONE"},{"key":"2865_CR157","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/biom12040576","volume":"12","author":"A Srivastava","year":"2022","unstructured":"Srivastava A, Alam P, Caughey B (2022) RT-QuIC and related assays for detecting and quantifying prion-like pathological seeds of \u03b1-synuclein. Biomolecules 12:576. https:\/\/doi.org\/10.3390\/biom12040576","journal-title":"Biomolecules"},{"key":"2865_CR158","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jalz.2019.01.012","volume":"16","author":"AM Staffaroni","year":"2020","unstructured":"Staffaroni AM, Bajorek L, Casaletto KB et al (2020) Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimer\u2019s Dement 16:11\u201321. https:\/\/doi.org\/10.1016\/j.jalz.2019.01.012","journal-title":"Alzheimer\u2019s Dement"},{"key":"2865_CR159","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.parkreldis.2015.08.006","volume":"21","author":"M Stamelou","year":"2015","unstructured":"Stamelou M, Diehl-Schmid J, Hapfelmeier A et al (2015) The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias. Parkinsonism Relat Disord 21:1264\u20131268. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.08.006","journal-title":"Parkinsonism Relat Disord"},{"key":"2865_CR160","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/mds.25509","volume":"28","author":"M Stamelou","year":"2013","unstructured":"Stamelou M, Quinn NP, Bhatia KP (2013) \u201cAtypical\u201d atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy\u2014a diagnostic guide. Mov Disord 28:1184\u20131199. https:\/\/doi.org\/10.1002\/mds.25509","journal-title":"Mov Disord"},{"key":"2865_CR161","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/mds.25880","volume":"29","author":"I Stankovic","year":"2014","unstructured":"Stankovic I, Krismer F, Jesic A et al (2014) Cognitive impairment in multiple system atrophy: a position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group. Mov Disord 29:857\u2013867. https:\/\/doi.org\/10.1002\/mds.25880","journal-title":"Mov Disord"},{"key":"2865_CR162","doi-asserted-by":"publisher","first-page":"104708","DOI":"10.1016\/j.nbd.2019.104708","volume":"134","author":"LE Stoyka","year":"2020","unstructured":"Stoyka LE, Arrant AE, Thrasher DR et al (2020) Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded \u03b1-synuclein inclusions. Neurobiol Dis 134:104708. https:\/\/doi.org\/10.1016\/j.nbd.2019.104708","journal-title":"Neurobiol Dis"},{"key":"2865_CR163","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.parkreldis.2022.01.004","volume":"95","author":"D Street","year":"2022","unstructured":"Street D, Whiteside D, Rittman T, Rowe JB (2022) Prediagnostic progressive supranuclear palsy\u2014insights from the UK biobank. Parkinsonism Relat Disord 95:59\u201364. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.01.004","journal-title":"Parkinsonism Relat Disord"},{"key":"2865_CR164","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.21037\/apm-22-1396","volume":"11","author":"M Sun","year":"2022","unstructured":"Sun M, Yan T, Liu R et al (2022) Predictive value of machine learning in diagnosing cognitive impairment in patients with Parkinson\u2019s disease: a systematic review and meta-analysis. Ann Palliat Med 11:3775\u20133784. https:\/\/doi.org\/10.21037\/apm-22-1396","journal-title":"Ann Palliat Med"},{"key":"2865_CR165","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/eb-2017-102848","volume":"21","author":"A Surendranathan","year":"2018","unstructured":"Surendranathan A, O\u2019Brien JT (2018) Clinical imaging in dementia with Lewy bodies. Evid Based Mental Health 21:61\u201365. https:\/\/doi.org\/10.1136\/eb-2017-102848","journal-title":"Evid Based Mental Health"},{"key":"2865_CR166","doi-asserted-by":"publisher","first-page":"105899","DOI":"10.1016\/j.nbd.2022.105899","volume":"175","author":"C-H Tai","year":"2022","unstructured":"Tai C-H, Tseng S-H (2022) Cerebellar deep brain stimulation for movement disorders. Neurobiol Dis 175:105899. https:\/\/doi.org\/10.1016\/j.nbd.2022.105899","journal-title":"Neurobiol Dis"},{"key":"2865_CR167","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.nicl.2018.09.028","volume":"20","author":"AS Talai","year":"2018","unstructured":"Talai AS, Sedlacik J, Boelmans K, Forkert ND (2018) Widespread diffusion changes differentiate Parkinson\u2019s disease and progressive supranuclear palsy. Neuroimage Clin 20:1037\u20131043. https:\/\/doi.org\/10.1016\/j.nicl.2018.09.028","journal-title":"Neuroimage Clin"},{"key":"2865_CR168","doi-asserted-by":"publisher","first-page":"103915","DOI":"10.1016\/j.ebiom.2022.103915","volume":"77","author":"S Tang","year":"2022","unstructured":"Tang S, Wang Y, Liu Y et al (2022) Large-scale network dysfunction in \u03b1-Synucleinopathy: a meta-analysis of resting-state functional connectivity. EBioMedicine 77:103915. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103915","journal-title":"EBioMedicine"},{"key":"2865_CR169","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/gps.4609","volume":"32","author":"AJ Thomas","year":"2017","unstructured":"Thomas AJ, Taylor JP, McKeith I et al (2017) Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study. Int J Geriatr Psychiatry 32:1280\u20131304. https:\/\/doi.org\/10.1002\/gps.4609","journal-title":"Int J Geriatr Psychiatry"},{"key":"2865_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000515008","volume":"50","author":"K Tsamakis","year":"2021","unstructured":"Tsamakis K, Mueller C (2021) Challenges in predicting cognitive decline in dementia with lewy bodies. Dement Geriatr Cogn Disord 50:1\u20138. https:\/\/doi.org\/10.1159\/000515008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2865_CR171","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41531-023-00565-2","volume":"9","author":"W Uchida","year":"2023","unstructured":"Uchida W, Kamagata K, Andica C et al (2023) Fiber-specific micro- and macroscopic white matter alterations in progressive supranuclear palsy and corticobasal syndrome. NPJ Parkinsons Dis 9:122. https:\/\/doi.org\/10.1038\/s41531-023-00565-2","journal-title":"NPJ Parkinsons Dis"},{"key":"2865_CR172","doi-asserted-by":"publisher","first-page":"105599","DOI":"10.1016\/j.nbd.2021.105599","volume":"163","author":"N Van Den Berge","year":"2022","unstructured":"Van Den Berge N, Ulusoy A (2022) Animal models of brain-first and body-first Parkinson\u2019s disease. Neurobiol Dis 163:105599. https:\/\/doi.org\/10.1016\/j.nbd.2021.105599","journal-title":"Neurobiol Dis"},{"key":"2865_CR173","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jnnp-2014-308004","volume":"86","author":"D Wagshal","year":"2015","unstructured":"Wagshal D, Sankaranarayanan S, Guss V et al (2015) Divergent CSF \u03c4 alterations in two common tauopathies: Alzheimer\u2019s disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 86:244\u2013250. https:\/\/doi.org\/10.1136\/jnnp-2014-308004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2865_CR174","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11910-018-0823-9","volume":"18","author":"RS Weil","year":"2018","unstructured":"Weil RS, Costantini AA, Schrag AE (2018) Mild cognitive impairment in Parkinson\u2019s disease\u2014what is it? Curr Neurol Neurosci Rep 18:17. https:\/\/doi.org\/10.1007\/s11910-018-0823-9","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2865_CR175","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L et al (2022) The Movement Disorder Society Criteria for the diagnosis of multiple system atrophy. Mov Disord 37:1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"key":"2865_CR176","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1212\/WNL.0b013e3181feb2e8","volume":"75","author":"JL Whitwell","year":"2010","unstructured":"Whitwell JL, Jack CR, Boeve BF et al (2010) Imaging correlates of pathology in corticobasal syndrome. Neurology 75:1879\u20131887. https:\/\/doi.org\/10.1212\/WNL.0b013e3181feb2e8","journal-title":"Neurology"},{"key":"2865_CR177","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2014.01.023","volume":"20","author":"JL Whitwell","year":"2014","unstructured":"Whitwell JL, Schwarz CG, Reid RI et al (2014) Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes. Parkinsonism Relat Disord 20:493\u2013498. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.01.023","journal-title":"Parkinsonism Relat Disord"},{"key":"2865_CR178","doi-asserted-by":"publisher","unstructured":"Yamada M, Komatsu J, Nakamura K, et al (2020) Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions. J Mov Disord 13:1\u201310. https:\/\/doi.org\/10.14802\/jmd.19052","DOI":"10.14802\/jmd.19052"},{"key":"2865_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101891","volume":"23","author":"H Yang","year":"2019","unstructured":"Yang H, Wang N, Luo X et al (2019) Cerebellar atrophy and its contribution to motor and cognitive performance in multiple system atrophy. Neuroimage Clin 23:101891. https:\/\/doi.org\/10.1016\/j.nicl.2019.101891","journal-title":"Neuroimage Clin"},{"key":"2865_CR180","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clinph.2019.09.026","volume":"131","author":"HG Yang","year":"2020","unstructured":"Yang HG, Luo XG, Yu HM et al (2020) Altered resting-state voxel-level whole-brain functional connectivity in multiple system atrophy patients with cognitive impairment. Clin Neurophysiol 131:54\u201362. https:\/\/doi.org\/10.1016\/j.clinph.2019.09.026","journal-title":"Clin Neurophysiol"},{"key":"2865_CR181","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jcsm.13143","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang Y, Xiao M, Leng L et al (2023) A systematic review and meta-analysis of the prevalence and correlation of mild cognitive impairment in sarcopenia. J Cachexia Sarcopenia Muscle 14:45\u201356. https:\/\/doi.org\/10.1002\/jcsm.13143","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2865_CR182","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/mds.29072","volume":"37","author":"R Ye","year":"2022","unstructured":"Ye R, O\u2019Callaghan C, Rua C et al (2022) Locus coeruleus integrity from 7 T MRI relates to apathy and cognition in Parkinsonian disorders. Mov Disord 37:1663\u20131672. https:\/\/doi.org\/10.1002\/mds.29072","journal-title":"Mov Disord"},{"key":"2865_CR183","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1111\/ene.15095","volume":"28","author":"HS Yoo","year":"2021","unstructured":"Yoo HS, Kwon H, Chung SJ et al (2021) Neural correlates of self-awareness of cognitive deficits in non-demented patients with Parkinson\u2019s disease. Eur J Neurol 28:4022\u20134030. https:\/\/doi.org\/10.1111\/ene.15095","journal-title":"Eur J Neurol"},{"key":"2865_CR184","doi-asserted-by":"publisher","first-page":"106020","DOI":"10.1016\/j.parkreldis.2024.106020","volume":"123","author":"AT Ysb\u00e6k-Nielsen","year":"2024","unstructured":"Ysb\u00e6k-Nielsen AT (2024) Connectome-based predictive modelling estimates individual cognitive status in Parkinson\u2019s disease. Parkinsonism Relat Disord 123:106020. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106020","journal-title":"Parkinsonism Relat Disord"},{"key":"2865_CR185","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.21037\/qims.2018.11.02","volume":"8","author":"L Zhang","year":"2018","unstructured":"Zhang L, Zhang L, Xue F et al (2018) Brain morphological alteration and cognitive dysfunction in multiple system atrophy. Quant Imaging Med Surg 8:1030\u20131038. https:\/\/doi.org\/10.21037\/qims.2018.11.02","journal-title":"Quant Imaging Med Surg"},{"key":"2865_CR186","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wu K-M, Yang L et al (2022) Tauopathies: new perspectives and challenges. Mol Neurodegener 17:28. https:\/\/doi.org\/10.1186\/s13024-022-00533-z","journal-title":"Mol Neurodegener"},{"key":"2865_CR187","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3390\/biomedicines11071996","volume":"11","author":"F Zhao","year":"2023","unstructured":"Zhao F, Behnisch T (2023) The enigmatic CA2: exploring the understudied region of the hippocampus and its involvement in Parkinson\u2019s disease. Biomedicines 11:1996. https:\/\/doi.org\/10.3390\/biomedicines11071996","journal-title":"Biomedicines"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02865-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-024-02865-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02865-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:34:41Z","timestamp":1740746081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-024-02865-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":187,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2865"],"URL":"https:\/\/doi.org\/10.1007\/s00702-024-02865-0","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our institution does not require ethical approval for narrative reviews.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}